Slovenia - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Slovenia Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry was up 4.5% year on year. In 2019, the country was ranked number 19 among other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry with $343,555,237.12 Million PPP. Slovenia is overtaken by Ireland, which was number 18 with $407,799,563.58 Million PPP and is followed by Netherlands at $289,193,594.01 Million PPP. United States topped the ranking with $70,565,318,932.39 Million PPP in 2019, +3.3% compared to 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland recorded the best 5 years average growth at +43.9% per year, while Lithuania recorded the worst performance at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 343,555,237.12 |
| 2018 | 333,279,784.98 |
| 2017 | 322,794,629.73 |
| 2016 | 311,587,198.79 |
| 2015 | 308,041,187.63 |
How does Slovenia rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 18 |
#18
Ireland
|
407,799,563.58 | 2019 | +3.8 % | +16.9 % | View data | |
| 19 |
#19
Slovenia
|
343,555,237.12 | 2019 | +3.1 % | +4.5 % | View data | |
| 20 |
#20
Netherlands
|
289,193,594.01 | 2019 | -3.4 % | -1.8 % | View data | |